Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
The study objective is to report a case of successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab (selective inhibitor, preventing the interaction between the programmed death receptor 1 (PD1) and its ligands PD-L1 and PD-L2).Materials and met...
Saved in:
| Main Authors: | A. M. Mudunov, I. М. Gelfand, О. D. Ryzhova, A. A. Akhundov, М. N. Narimanov, A. V. Ignatova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-04-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: A. M. Mudunov, et al.
Published: (2017-06-01) -
Pembrolizumab in treatment of head and neck squamous cell carcinoma: clinical cases and real-world practice
by: Yu. V. Alymov, et al.
Published: (2023-09-01) -
An update on head and neck squamous cell carcinoma in respect to classification and systemic therapy. Extended review
by: A. Mudunov, et al.
Published: (2018-04-01) -
Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck
by: Allen M. Chen, et al.
Published: (2025-03-01) -
Influence of the results of international studies on the choice of treatment tactics for unresectable forms of squamous cell carcinoma of the head and neck
by: L. V. Bolotina, et al.
Published: (2020-07-01)